Rho Kinase Elevated IOP Treatment (ROCKET) trials


February 1, 2018

Clinical trial

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).

Serle JB, Katz LJ, McLaurin E, Heah T, Ramirez-Davis N, Usner DW, Novack GD, Kopczynski CC.

Am J Ophthalmol. 2018 Feb;186:116-127.
Full text | Metrics.

August 1, 2019

Clinical trial

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study.

Khouri AS, Serle JB, Bacharach J, Usner DW, Lewis RA, Braswell P, Kopczynski CC, Heah T.

Am J Ophthalmol. 2019 Aug;204:97-104.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive